Department of Clinical
Hematology and Medical Oncology
What's unique about us?
This department brings trained and experienced medical oncologists and hematologists to cancer patients and patients with various hematological disorders under one roof. Anticancer chemotherapy and modern targeted therapies are systemic treatments that can produce life-threatening systemic side effects. The side-effects can range from blood and bone marrow dysfunction, disseminated infections, significant organ dysfunction like liver, kidneys, & heart failure, toxicities to the brain, digestive tracts, and hormonal imbalance. The department has a strong team of trained physicians with decades of experience managing these serious side effects. All the faculty members in the department work in close collaboration to provide the latest medical anticancer treatment to the patients coming to PGI.
Our History
PGIMER has started a new Department of Clinical Hematology and Medical Oncology from September 2021. The clinical hematology services were previously discharged through the department of internal medicine. The clinical hematology services consist of diagnosis and treatment of benign hematological disorders ranging from causes of anemia, immune thrombocytopenia (platelet disorders), aplastic anemia, hemoglobinopathies (thalassemia, sickle cell anemia), bleeding and clotting disorders (hemophilia, deep venous thrombosis, pulmonary embolism) and treatment of malignant disorders like acute leukemia, lymphoma, myeloma, myelodysplastic syndromes, myeloproliferative neoplasms etc.
The department also has a robust hematopoietic cell (bone marrow or stem cell) transplant program since 2003 onwards. At present, all major types of transplants like matched sibling donor transplant, matched unrelated donor transplant, haploidentical hematopoietic cell transplant, autologous hematopoietic cell transplants, etc., are being performed regularly. Since the beginning of transplant program, around 500 patients have received hematopoietic stem cell transplant at our center for illnesses like leukemia, aplastic anemia, multiple myeloma, lymphoma, thalassemia and primary immunodeficiency.
The medical oncology services manage all types of solid cancer patients with complex chemotherapy, immunotherapy, transplant and cellular therapies like Chimeric Antigen Receptor T cell therapies. The department has experienced faculty members trained in diagnosing, evaluating, and treating cancers of all subtypes.